106 related articles for article (PubMed ID: 2436648)
1. Plasma fibrinolysis during and after normal childbirth.
Mackinnon S; Walker ID; Davidson JF; Walker JJ
Br J Haematol; 1987 Mar; 65(3):339-42. PubMed ID: 2436648
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors and activators of fibrinolysis during and after childbirth in maternal and cord blood.
Runnebaum IB; Maurer SM; Daly L; Bonnar J
J Perinat Med; 1989; 17(2):113-9. PubMed ID: 2509671
[TBL] [Abstract][Full Text] [Related]
3. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
4. [Changes of fibrinolysis during labour with and without aprotinin application].
Kühnert M; Stein W; Tekesin I; Hellmeyer L; Schmidt S
Z Geburtshilfe Neonatol; 2003; 207(3):90-100. PubMed ID: 12891467
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors.
Kruithof EK; Tran-Thang C; Gudinchet A; Hauert J; Nicoloso G; Genton C; Welti H; Bachmann F
Blood; 1987 Feb; 69(2):460-6. PubMed ID: 2432970
[TBL] [Abstract][Full Text] [Related]
6. [Studies on coagulation-fibrinolysis during normal pregnancy, labor and puerperium using recently developed molecular markers].
Komatsu Y
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):627-34. PubMed ID: 7636333
[TBL] [Abstract][Full Text] [Related]
7. Effects of labor and delivery on fibrinolysis.
Bremer HA; Brommer EJ; Wallenburg HC
Eur J Obstet Gynecol Reprod Biol; 1994 Jun; 55(3):163-8. PubMed ID: 7958159
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic activity and protein C in preeclampsia.
Aznar J; Gilabert J; Estellés A; España F
Thromb Haemost; 1986 Jun; 55(3):314-7. PubMed ID: 3092388
[TBL] [Abstract][Full Text] [Related]
10. Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy.
Koh SC; Anandakumar C; Biswas A; Fong YF
Thromb Haemost; 2002 Jan; 87(1):175-6. PubMed ID: 11858184
[No Abstract] [Full Text] [Related]
11. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time.
Wright JG; Cooper P; Astedt B; Lecander I; Wilde JT; Preston FE; Greaves M
Br J Haematol; 1988 Jun; 69(2):253-8. PubMed ID: 3134043
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activators and inhibitors in normal late pregnancy, postpartum and in the postnatal period.
Koh CL; Viegas OA; Yuen R; Chua SE; Ng BL; Ratnam SS
Int J Gynaecol Obstet; 1992 May; 38(1):9-18. PubMed ID: 1348996
[TBL] [Abstract][Full Text] [Related]
13. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
14. The influence of labor on thrombotic and fibrinolytic systems.
Yoshimura T; Ito M; Nakamura T; Okamura H
Eur J Obstet Gynecol Reprod Biol; 1992 May; 44(3):195-9. PubMed ID: 1535054
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis after hip replacement. Relationship to the fibrinolytic system.
Eriksson BI; Eriksson E; Gyzander E; Teger-Nilsson AC; Risberg B
Acta Orthop Scand; 1989 Apr; 60(2):159-63. PubMed ID: 2471386
[TBL] [Abstract][Full Text] [Related]
16. Tissue plasminogen activator and plasminogen activator inhibitors of type 1 and type 2 in the plasma of parturient women.
Uszyński M; Uszyński W; Zekanowska E; Garbacz J; Kielkowski A; Marcinkowski Z
J Perinat Med; 1996; 24(4):339-45. PubMed ID: 8880631
[TBL] [Abstract][Full Text] [Related]
17. Hemostasis during normal pregnancy and puerperium.
Hellgren M
Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
[TBL] [Abstract][Full Text] [Related]
18. Levels of fibrinolytic activators and inhibitors in plasma after severe trauma.
Sørensen JV
Blood Coagul Fibrinolysis; 1994 Feb; 5(1):43-9. PubMed ID: 7514044
[TBL] [Abstract][Full Text] [Related]
19. Influence of delivery on plasminogen activator inhibitor activity.
Koelbl H; Kirchheimer J; Tatra G
J Perinat Med; 1989; 17(2):107-11. PubMed ID: 2681664
[TBL] [Abstract][Full Text] [Related]
20. Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications.
Lucore CL; Sobel BE
Circulation; 1988 Mar; 77(3):660-9. PubMed ID: 2449299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]